• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素β-1a对多发性硬化症患者血浆细胞因子水平的急性影响。

Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS.

作者信息

Kümpfel T, Then Bergh F, Pollmächer T, Holsboer F, Trenkwalder C

机构信息

Max Planck Institute of Psychiatry, Section of Neurology, Munich, Germany.

出版信息

Neurology. 2000 Oct 24;55(8):1231-3. doi: 10.1212/wnl.55.8.1231.

DOI:10.1212/wnl.55.8.1231
PMID:11071509
Abstract

The acute effects of a i.m. injection of interferon beta-1a on the secretion of the cytokines interleukin-6, tumor necrosis factor-alpha, soluble tumor necrosis factor receptor I, and interleukin-1 receptor antagonist and its relation to peripheral concentrations of adrenocorticotropic hormone (ACTH) and cortisol in patients with MS were investigated, as well as the influence of cotreatment with indomethacin on these parameters. After interferon beta injection we found an acute rise in plasma cytokine levels and an increase in plasma hormone concentrations, both of which were modulated by indomethacin comedication.

摘要

研究了肌肉注射干扰素β-1a对多发性硬化症患者细胞因子白细胞介素-6、肿瘤坏死因子-α、可溶性肿瘤坏死因子受体I和白细胞介素-1受体拮抗剂分泌的急性影响及其与促肾上腺皮质激素(ACTH)和皮质醇外周浓度的关系,以及吲哚美辛联合治疗对这些参数的影响。注射干扰素β后,我们发现血浆细胞因子水平急性升高,血浆激素浓度增加,两者均受到吲哚美辛联合用药的调节。

相似文献

1
Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS.干扰素β-1a对多发性硬化症患者血浆细胞因子水平的急性影响。
Neurology. 2000 Oct 24;55(8):1231-3. doi: 10.1212/wnl.55.8.1231.
2
Time of interferon-beta 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients.干扰素β-1a注射时间和治疗持续时间会影响多发性硬化症患者的临床副作用以及血浆激素和细胞因子水平的急性变化。
Mult Scler. 2007 Nov;13(9):1138-45. doi: 10.1177/1352458507078685.
3
In vivo effect of interferon-beta 1a on interleukin-12 and TGF-beta(1) cytokines in patients with relapsing-remitting multiple sclerosis.干扰素β-1a对复发缓解型多发性硬化症患者白细胞介素-12和转化生长因子-β(1)细胞因子的体内作用
Acta Neurol Scand. 2002 Jul;106(1):44-6. doi: 10.1034/j.1600-0404.2002.01209.x.
4
Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis.多发性硬化症患者接受6个月的β-1a干扰素治疗后,促炎细胞因子和抗炎细胞因子均减少。
J Neuroimmunol. 2000 Mar 1;103(2):202-10. doi: 10.1016/s0165-5728(99)00184-8.
5
Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis.干扰素β-1a在多发性硬化症中的急慢性神经内分泌效应
Clin Endocrinol (Oxf). 2007 Feb;66(2):295-303. doi: 10.1111/j.1365-2265.2006.02725.x.
6
IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis.干扰素β-1a可能会提高复发缓解型多发性硬化症患者的基质金属蛋白酶组织抑制因子-1血清水平。
J Interferon Cytokine Res. 2001 Mar;21(3):181-5. doi: 10.1089/107999001750133230.
7
Effects of interferon β-1a and interferon β-1b monotherapies on selected serum cytokines and nitrite levels in patients with relapsing-remitting multiple sclerosis: a 3-year longitudinal study.干扰素 β-1a 和干扰素 β-1b 单药治疗对复发缓解型多发性硬化症患者选定血清细胞因子和亚硝酸盐水平的影响:一项 3 年纵向研究。
Neuroimmunomodulation. 2013;20(4):213-22. doi: 10.1159/000348701. Epub 2013 May 24.
8
Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients.干扰素-β调节多发性硬化症患者的骨相关细胞因子和破骨细胞前体活性。
Mult Scler. 2006 Oct;12(5):541-50. doi: 10.1177/1352458506070605.
9
Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosis.皮下注射重组干扰素β-1a(利比)治疗复发缓解型多发性硬化症的研究聚焦
BioDrugs. 2005;19(5):323-5. doi: 10.2165/00063030-200519050-00005.
10
[Interferons beta in patients with multiple sclerosis].[多发性硬化症患者中的β干扰素]
Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(7):54-5.

引用本文的文献

1
Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-β1b Treatment for Multiple Sclerosis.长期使用β-1b干扰素治疗多发性硬化症后出现肠道受累的血栓性微血管病
Intern Med. 2018 Mar 1;57(5):741-744. doi: 10.2169/internalmedicine.9326-17. Epub 2017 Nov 20.
2
Relationship between Interferon Beta-1A Administration and Intracranial Vascular Tone Regulation in Patients with Relapsing-Remitting Multiple Sclerosis: A Pilot Study.干扰素 β-1A 给药与复发缓解型多发性硬化患者颅内血管张力调节的关系:一项初步研究。
Biomed Res Int. 2017;2017:5421416. doi: 10.1155/2017/5421416. Epub 2017 Sep 13.
3
The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.
细胞因子作为免疫调节疗法对多发性硬化症心理影响的一种可能底物的作用。
Neurosci Behav Physiol. 2009 Jan;39(1):25-30. doi: 10.1007/s11055-008-9087-1.
4
Melanoma inhibition by cyclooxygenase inhibitors: role of interleukin-6 suppression, a putative mechanism of action, and clinical implications.环氧合酶抑制剂对黑色素瘤的抑制作用:白细胞介素-6抑制的作用、一种可能的作用机制及临床意义。
Med Oncol. 2007;24(1):1-6. doi: 10.1007/BF02685897.
5
Intramuscular interferon-beta-1a: in patients at high risk of developing clinically definite multiple sclerosis.肌肉注射干扰素β-1a:用于有发展为临床确诊多发性硬化症高风险的患者。
CNS Drugs. 2005;19(1):55-61; discussion 63-4. doi: 10.2165/00023210-200519010-00005.